Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostasin (PRSS8) is a membrane-bound serine protease of the trypsin family, highly expressed in epithelial tissues such as the prostate, lung, and skin[5][6]. Its principal roles include promoting terminal differentiation in epithelia and regulating epithelial sodium channel (ENaC) activity, essential for sodium and water homeostasis. Prostasin achieves its functions both through its enzymatic activity and via non-catalytic mechanisms, as demonstrated by mouse models where enzymatic inactivation does not abrogate key biological functions[4]. Disease associations primarily relate to barrier dysfunction, dehydration, and conditions involving abnormal sodium transport. Experimental and pharmacological efforts to target prostasin focus on protease inhibition, which may impact epithelial integrity and fluid balance.
Protease inhibitors can block the catalytic site of prostasin, typically by mimicking substrate and forming stable complexes. Regulation/inhibition of enzymatic activity impacts ENaC channel function, affecting salt and water absorption[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostasin (PRSS8).